| Application no. and date | 22729925.2 (espacenet) (Federated) (European Patent Register), 20220517 | | Patent/reg. no. and date | DK/EP 4340842, 20250827 | | Publication date | 20240327 | | Priority no. and date | US 202163190061 P, 20210518 | | EP pub. no. and date |
EP 4340842 20240327 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320, US | | Applicant ref. no. | 2031877 | | Inventor | HENARY, Haby,
Thousand Oaks, California 91320-1799, US,
NGARMCHAMNANRITH, Gataree,
Thousand Oaks, California 91320-1799, US,
FRIBERG, Gregory,
Thousand Oaks, California 91320-1799, US,
HOUK, Brett E.,
Thousand Oaks, California 91320-1799, US,
DUTTA, Sandeep,
Thousand Oaks, California 91320-1799, US,
PARK, Joseph,
Thousand Oaks, California 91320-1799, US,
MATHER, Omar,
Thousand Oaks, California 91320-1799, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | SOTORASIB TIL ANVENDELSE VED BEHANDLING AF KRÆFT | | Int. application no. | US2022029677 | | Int. publication no. | WO2022245857 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
